Mammograms Specialist Lincoln RI

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct. It is not cancer, but it may, in some cases, become invasive cancer and spread to other tissues. Because they can’t predict which lesions will become invasive cancer and which will remain contained in the breast duct, doctors usually treat DCIS like cancer.

Nancy Jane Freeman, MD
401-273-7100 x3450
8 Whitney Dr
Lincoln, RI
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: New York Med Coll, Valhalla Ny 10595
Graduation Year: 1981

Data Provided by:
Kathy P Theall, MD
(401) 729-2700
111 Brewster St
Pawtucket, RI
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Esc Colombiana De Med, Bogota, Colombia
Graduation Year: 1989

Data Provided by:
Edward Moo-Woong Choi, MD
(570) 829-8111
126 Prospect St
Pawtucket, RI
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Seoul Natl Univ, Coll Of Med, Chongno-Ku, Seoul, So Korea
Graduation Year: 1967

Data Provided by:
David Arthur Pomerantz, MD
333 School St
Pawtucket, RI
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Vt Coll Of Med, Burlington Vt 05405
Graduation Year: 1992

Data Provided by:
Sabrina Maria Witherby
(401) 729-2700
111 Brewster St
Pawtucket, RI
Specialty
Hematology / Oncology

Data Provided by:
Maen A Hussein
(401) 658-2020
106 Nate Whipple Hwy
Cumberland, RI
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Linda Rosarina Hassan, MD
(401) 728-5900
73 Beechwood Ave
Pawtucket, RI
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Rochester Sch Of Med & Dentistry, Rochester Ny 14642
Graduation Year: 1979

Data Provided by:
Linda Rosarina Hassan
(401) 724-4040
73 Beechwood Ave
Pawtucket, RI
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Arvin S Glicksman, MD
(401) 728-4800
249 Roosevelt Ave Unit 201
Pawtucket, RI
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Finch U Of Hs/Chicago Med Sch, North Chicago Il 60664
Graduation Year: 1949

Data Provided by:
Arvin S Glicksman
(401) 728-4835
249 Roosevelt Ave
Pawtucket, RI
Specialty
Radiation Oncology

Data Provided by:
Data Provided by:

Mandatory Mammograms

Provided by: 

By Vonalda M. Utterback, CN

“Time to make breast pancakes,” says one friend of mine, referring to her scheduled mammography screening. And although she may crack jokes about the experience, she’s never once questioned the need for her annual pilgrimage, nor has her physician discussed the risks versus the benefits it entails. After all, if you are a woman aged 40 or beyond, yearly mammograms are simply de rigueur.

When your doctor refers you for a screening, he or she is likely following the guidelines of the two leading national cancer research and information organizations primarily responsible for setting public health policy on cancer screening: The private American Cancer Society (ACS) and the government’s National Cancer Institute (NCI). Both, along with other well-funded, high-profile organizations, such as Susan G. Komen for the Cure, recommend regular mammogram screening of symptom-free women beginning at age 40.

All this official blessing shouldn’t make regular screening mammography sacrosanct, however. In fact, it’s way past time for women to start asking hard questions about the exam’s efficacy and its potential harm, say many women’s health experts, advocates, and researchers. “Screening mammography is clearly a double-edged sword,” explains Lisa Schwartz, MD, co-director of the Veteran’s Administration Outcomes Group in White River Junction, Vermont, and associate professor of medicine at Dartmouth Medical School.

False truths
According to the National Academy of Sciences 2005 publication, Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis, the risk of a false-positive result in a mammogram is about 1 in 10. About three-quarters of the resulting biopsies turn out to be benign, it’s true, but to learn that a woman has to endure the fear that she has breast cancer and bear the cost, discomfort, and risk of additional medical procedures.

“Regular screening will save some lives, but it will cause even more women to be harmed through the unnecessary diagnosis and treatment of cancer that would never have affected their health, were it not for screening,” says Schwartz. She’s referring to false-positives associated with “ductal carcinoma in situ” (DCIS), a result that many experts consider one of the most harmful risks associated with screening mammography.

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct. It is not cancer, but it may, in some cases, become invasive cancer and spread to other tissues. Because they can’t predict which lesions will become invasive cancer and which will remain contained in the breast duct, doctors usually treat DCIS like cancer. “Most women with DCIS will be advised to undergo invasive treatment of unknown benefit, such as lumpectomy combined with radiation,” reports Schwartz.
Harm from over-diagnosis of invasive cancer also may occur because many malignant cancers grow quite slowly, says Peter C. Gotzsche, MD, r...

Author: Vonalda M. Utterback, CN

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...